Rotavirus antibodies in the mother and her breast-fed infant.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 2991489)

Published in J Pediatr Gastroenterol Nutr on June 01, 1985

Authors

K Hjelt, P C Grauballe, O H Nielsen, P O Schiøtz, P A Krasilnikoff

Articles by these authors

Familial occurrence of inflammatory bowel disease. N Engl J Med (1991) 2.95

Relationship between infant feeding and infectious illness: a prospective study of infants during the first year of life. Pediatrics (1990) 2.30

Safety and efficacy of recombinant human interleukin 10 in chronic active Crohn's disease. Crohn's Disease IL-10 Cooperative Study Group. Gastroenterology (2000) 2.21

Chronic inflammation: importance of NOD2 and NALP3 in interleukin-1beta generation. Clin Exp Immunol (2007) 2.12

Incidence and prevalence of Crohn's disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol (1992) 2.09

Optimized enzyme-linked immunosorbent assay for detection of human and bovine rotavirus in stools: Comparison with electron-microscopy, immunoelectro-osmophoresis, and fluorescent antibody techniques. J Med Virol (1981) 2.04

Technique of small intestinal biopsy: use of a pediatric Watson intestinal biopsy capsule combined with administration of cisapride. J Pediatr Gastroenterol Nutr (1996) 1.93

An open-labeled, randomized study comparing systemic interferon-alpha-2A and prednisolone enemas in the treatment of left-sided ulcerative colitis. Am J Gastroenterol (2001) 1.88

Intermittent muscular weakness, extrasystoles, and multiple developmental anomalies. A new syndrome? Acta Paediatr Scand (1971) 1.83

Effect of passive smoking on birth-weight. Lancet (1986) 1.75

Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol (1991) 1.73

The role of immune complexes in the pathogenesis of bacterial infections. Annu Rev Microbiol (1986) 1.67

Monitoring of omeprazole treatment in gastro-oesophageal reflux disease. Eur J Gastroenterol Hepatol (1996) 1.45

Identification of a basophil leukocyte interleukin-3-regulated protein that is identical to IgE-dependent histamine-releasing factor. Allergy (1998) 1.42

Role of Pseudomonas aeruginosa exoenzymes in lung infections of patients with cystic fibrosis. Infect Immun (1985) 1.41

ELISA for herpes simplex virus (HSV) type-specific antibodies in human sera using HSV type 1 and type 2 polyspecific antigens blocked with type-heterologous rabbit antibodies. Acta Pathol Microbiol Scand B (1979) 1.40

Lectins interact differentially with purified human eosinophils, cultured cord blood-derived mast cells and the myeloid leukaemic cell line AML14.3D10: induction of interleukin-4 secretion is conserved among granulocytes, but is not proportional to agglutination or lectin-glycoprotein interaction. Clin Exp Allergy (2003) 1.39

Insulin-like growth factor-I in celiac disease. J Pediatr Gastroenterol Nutr (1994) 1.38

Assessment of the validity of a multigene analysis in the diagnostics of inflammatory bowel disease. J Intern Med (2013) 1.38

Normal levels of gliadin antibodies in symptomless celiac disease. Dig Dis Sci (1988) 1.38

[Neonatal mortality, morbidity and late sequelae in infants with birth weight under 1.501 gr or gestational age under 31 weeks, primarily admitted to a central hospital]. Ugeskr Laeger (1995) 1.38

Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr (1994) 1.34

Pregnancy in ulcerative colitis. Scand J Gastroenterol (1983) 1.33

Rapid diagnosis of rotavirus infections: comparison of electron microscopy and immunoelectroosmophoresis for the detection of rotavirus in human infantile gastroenteritis. J Gen Virol (1977) 1.30

Inflammatory bowel diseases with onset in childhood. Clinical features, morbidity, and mortality in a regional cohort. Scand J Gastroenterol (1997) 1.28

Asthma and atopy - a total genome scan for susceptibility genes. Allergy (2002) 1.28

Non-tropical sprue. Malignant diseases and mortality rate. Scand J Gastroenterol (1985) 1.27

Rapid diagnosis by immunofluorescence of viral infections associated with the croup syndrome in children. Acta Pathol Microbiol Scand B Microbiol Immunol (1974) 1.21

Crossed immunoelectrophoretic studies of the solubility immunogenicity of herpes simplex virus antigens. J Virol (1977) 1.21

Increased numbers of interleukin-15-expressing cells in active ulcerative colitis. Am J Gastroenterol (1996) 1.18

Titration of herpes simplex virus antibodies in human sera by the enzyme-linked immunosorbent assay (ELISA). Acta Pathol Microbiol Scand B (1977) 1.17

High prevalence rates of adult silent coeliac disease, as seen in Sweden, must be expected in Denmark. APMIS (2001) 1.15

Interleukin 10 (Tenovil) in the prevention of postoperative recurrence of Crohn's disease. Gut (2001) 1.15

Expression of cyclooxygenase-2 mRNA in active inflammatory bowel disease. Am J Gastroenterol (1997) 1.14

National registry diagnoses agree with medical records on hospitalized asthmatic children. Acta Paediatr (2007) 1.14

Detection by ELISA of IgA and IgM antibodies in secretion and IgM antibodies in serum in primary lower respiratory syncytial virus infection. J Med Virol (1984) 1.13

Mitogen activated protein kinases: a role in inflammatory bowel disease? Clin Exp Immunol (2009) 1.13

Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol (1996) 1.12

Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study. Arch Dis Child (1984) 1.12

Diagnostic value of disaccharide tolerance tests in children. Acta Paediatr Scand (1975) 1.11

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid. Gastroenterology (1990) 1.09

Pregnancy in Crohn's disease. Scand J Gastroenterol (1984) 1.07

Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients. Acta Pathol Microbiol Immunol Scand C (1984) 1.07

Elastase from polymorphonuclear leucocytes: a regulatory enzyme in immune complex disease. Clin Exp Immunol (1986) 1.07

Pathogenic mechanisms of chronic Pseudomonas aeruginosa infections in cystic fibrosis patients. Antibiot Chemother (1971) (1987) 1.07

Cystic fibrosis in Denmark 1945 to 1985. An analysis of incidence, mortality and influence of centralized treatment on survival. Acta Paediatr Scand (1988) 1.07

Protective effect of preexisting rotavirus-specific immunoglobulin A against naturally acquired rotavirus infection in children. J Med Virol (1987) 1.06

Insulin resistance in skeletal muscles in patients with NIDDM. Diabetes Care (1992) 1.05

Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin. Eur J Respir Dis (1982) 1.05

Production of antiserum to respiratory syncytial virus polypeptides: application in enzyme-linked immunosorbent assay. J Clin Microbiol (1981) 1.05

Autoantibodies in serum and sputum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C (1979) 1.05

Cross-reactions between Haemophilus influenzae and nineteen other bacterial species. Acta Pathol Microbiol Scand B (1979) 1.03

The incidence of anemia, hypoproteinemia, and edema in infants as presenting symptoms of cystic fibrosis: a retrospective survey of the frequency of this symptom complex in 130 patients with cystic fibrosis. J Pediatr Gastroenterol Nutr (1982) 1.02

Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine (2000) 1.01

Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980. A statistical estimate of prognosis based on 253 cases. Cancer (1986) 1.01

Effect of amiloride on electrical activity and electrolyte transport in human colon. Scand J Gastroenterol (1977) 1.01

Immune complexes in the sputum of patients with cystic fibrosis suffering from chronic Pseudomonas aeruginosa lung infection. Acta Pathol Microbiol Scand C (1978) 1.00

A role for interleukin-33 in T(H)2-polarized intestinal inflammation? Mucosal Immunol (2011) 1.00

The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier. Clin Immunol (2006) 1.00

Improved in vivo insulin effect during continuous subcutaneous insulin infusion in patients with IDDM. Diabetes (1984) 0.99

Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol (2000) 0.99

Mast cells and atopic dermatitis. Stereological quantification of mast cells in atopic dermatitis and normal human skin. Arch Dermatol Res (1997) 0.99

Steady-state kinetics of 5-aminosalicylic acid and sulfapyridine during sulfasalazine prophylaxis in ulcerative colitis. Scand J Gastroenterol (1986) 0.99

Demonstration by immunoelectro-osmophoresis of precipitating antibodies to a purified rubella virus antigen. Infect Immun (1975) 0.98

Comparative studies of the colonic in situ expression of intercellular adhesion molecules (ICAM-1, -2, and -3), beta2 integrins (LFA-1, Mac-1, and p150,95), and PECAM-1 in ulcerative colitis and Crohn's disease. Am J Surg Pathol (2000) 0.97

Cytokines (immunoinflammatory hormones) and their natural regulation in inflammatory bowel disease (Crohn's disease and ulcerative colitis): a review. Dig Dis (1995) 0.97

Human mast cells express receptors for IL-3, IL-5 and GM-CSF; a partial map of receptors on human mast cells cultured in vitro. Allergy (2004) 0.96

The antiinflammatory moiety of sulfasalazine, 5-aminosalicylic acid, is a radical scavenger. Agents Actions (1987) 0.96

Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency. Int J Pediatr Endocrinol (2010) 0.96

Ontogeny of human mannan-binding protein, a lectin of the innate immune system. Pediatr Allergy Immunol (1995) 0.96

Antibody response in serum and intestine in children up to six months after a naturally acquired rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr (1986) 0.95

Cross-reactions between Staphylococcus aureus and fifteen other bacterial species. Acta Pathol Microbiol Scand B (1979) 0.95

Interobserver variation in diagnosing coeliac disease. A joint study by Danish and Swedish pathologists. APMIS (2000) 0.94

Gastric emptying rate and small bowel transit time in patients with irritable bowel syndrome determined with 99mTc-labeled pellets and scintigraphy. Dig Dis Sci (1986) 0.94

Priming of neutrophils for enhanced oxidative burst by sputum from cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest (1987) 0.94

Abnormal metabolism of arachidonic acid in chronic inflammatory bowel disease: enhanced release of leucotriene B4 from activated neutrophils. Gut (1987) 0.94

Several genetic and environmental factors influence cord blood IgE concentration. Pediatr Allergy Immunol (1994) 0.94

Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis. A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: influence of local steroid treatment. Acta Paediatr Scand (1983) 0.93

Parietal cell secretory function in early childhood. Scand J Gastroenterol (1967) 0.93

Sulfasalazine intolerance. A retrospective survey of the reasons for discontinuing treatment with sulfasalazine in patients with chronic inflammatory bowel disease. Scand J Gastroenterol (1982) 0.93

Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev Infect Dis (1991) 0.92

Crossed immunoelectrophoretic identification of partially purified type common and type specific herpes simplex virus glycoprotein antigens. Proc Soc Exp Biol Med (1977) 0.92

Intestinal and serum immune response to a naturally acquired rotavirus gastroenteritis in children. J Pediatr Gastroenterol Nutr (1985) 0.92

Demonstration of neutrophil chemotactic activity in the sputum of cystic fibrosis patients with Pseudomonas aeruginosa infection. Eur J Clin Invest (1986) 0.91

IgA and IgG antibodies against surface antigens of Pseudomonas aeruginosa in sputum and serum from patients with cystic fibrosis. Acta Pathol Microbiol Scand C (1979) 0.91

Cytokines in inflammatory bowel disease. Scand J Gastroenterol (1992) 0.91

ELISA for herpes simplex virus type 2 antibodies. Lancet (1977) 0.91

Cryptorchidism and testis cancer. Atypical infantile germ cells followed by carcinoma in situ and invasive carcinoma in adulthood. Cancer (1984) 0.91

Arachidonic acid metabolism in human neutrophils: lack of effect of cyclosporine A. Int J Immunopharmacol (1986) 0.90

Normally-occurring precipitating antibodies against Staphylococcus aureus in human serum and colostrum. Acta Pathol Microbiol Scand C (1981) 0.90